Protective effect of liraglutide on the myocardium of type 2 diabetic rats by inhibiting polyadenosine diphosphate-ribose polymerase-1

Table 3 Expression of polyadenosine diphosphate-ribose polymerase-1 in myocardial tissue of rats in each group (mean ± SD)

Group	Number	PARP-1
N	8	10.92 ± 3.59
M	8	58.12 ± 5.31a
LL	8	42.83 ± 1.14ab
HL	8	23.61 ± 0.92abc

^aP < 0.05, compared with group N.

^bP < 0.05, compared with group M.

^cP < 0.05, compared with group LL.

PARP-1: Polyadenosine diphosphate-ribose polymerase-1; N: Normal control; M: Model; HL: High-dose liraglutide; LL: Low-dose liraglutide.